Page 77 - Read Online

Page 8 of 9 Peek et al. Mini-invasive Surg 2024;8:11 https://dx.doi.org/10.20517/2574-1225.2024.47

for improved tolerance. Patients can expect discharge on the 4th or 5th day and should be closely monitored
with an early return to the clinic. It is important to inquire about their eating, drinking, and bowel function,
evaluate patients, and discuss with their families regarding general signs of failure to thrive.

CONCLUSION
The rise of adenocarcinoma as the dominant esophageal cancer subtype in the United States and Western
nations necessitates continuously reevaluating treatment guidelines and techniques to optimize patient
outcomes. While the current standard for advanced-stage disease incorporates a multimodal approach
integrating chemotherapy, radiation, and surgery, the field of esophageal oncology has witnessed a
remarkable evolution, transitioning from rudimentary procedures to contemporary minimally invasive
techniques exemplified by robotic esophagectomy. This technological advancement signifies a pivotal
milestone in surgical innovation, demonstrably paving the way for less invasive approaches with the
potential for reduced postoperative complications and shorter hospital stays.

The Da Vinci robotic surgical platform represents a noteworthy contribution to abdominal surgery, offering
enhanced precision, improved visualization, and potentially expedited patient recovery. While initial cost
considerations may pose a challenge, the integration of robotic technology has the potential to broaden the
eligibility criteria for procedures such as esophagectomy. Continued advancements in both hardware and
software are anticipated to further refine robotic surgery, ultimately improving patient outcomes.
Furthermore, the burgeoning field of AI and personalized medicine holds promise for developing optimized
treatment strategies, potentially improving survival rates for patients afflicted with esophageal carcinoma.

As the field of Surgery continues to evolve, the paramount objective remains to maximize patient outcomes
through the continuous refinement of surgical techniques, ensuring the sustained success of robotic-assisted
procedures in this patient population.

DECLARATIONS
Authors’ contributions
Data collection, drafting the article: Peek G
Conceptualization and design of the study, data analysis and interpretation, critical revision of the article,
final approval of the version to be published: Peek G, Ross SB

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
Ross SB is a consultant for Medtronic, Johnson & Johnson, Qventus, Caresyntax, Boston Scientific, and
serves as a consultant, proctor, and advisory board member for Intuitive Surgical. Other authors declared
that there are no conflicts of interest.

Ethical approval and consent to participate
Consent to participate was obtained from all patients in this study prior to their procedures.